Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page
- ChecktodayChange DetectedThe study's recruitment status now indicates it is no longer looking for participants, signaling halted enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision note (v3.6.0) with a formatting change to the Intervention/Treatment header was introduced.SummaryDifference0.6%

- Check7 days agoChange DetectedThe revision tag on the page updated from v3.5.4 to v3.5.5. This indicates a minor page update rather than changes to the study data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a newer build of the page. This update appears to be a maintenance change and does not alter study details or visible content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a backend or interface release rather than a change to the trial record content.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check86 days agoChange DetectedPage version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.